VENTREZYME T4 IMMUNOASSAY T4— 510(k) K840473

Substantially Equivalent

Vxr, Inc.

FDA 510(k) clearance K840473 for VENTREZYME T4 IMMUNOASSAY T4, Substantially Equivalent on 1984-04-04. Applicant: Vxr, Inc.. Device class: 2.

Clearance details

Applicant: Vxr, Inc.
Product code: Code KLI
Device class: Class 2
Regulation: 21 CFR 862.1700
Advisory panel: Clinical Chemistry
Date received: 1984-02-03
Decision date: 1984-04-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KLI

K160495 — VITROS® Automation Solutions2016-10-18
K131515 — ACE -GT REAGENT; ACE LIPASE RAGENT; ACE T4 REAGENT2013-08-14
K103484 — GSP NEONATAL THYROXINE (T4)2011-04-22
K082638 — ADVIA CENTAUR SYSTEM WITH STREAMLAB ANALYTICAL WORKCELL2009-02-26
K030860 — ACCUBIND NEONATAL T4 MICROPLATE EIA, MODEL 2625-3002003-08-22

More clearances from Vxr, Inc.

K853703 — VENTREZYME T3 IMMUNOASSAY T31985-10-04
K853748 — VENTRESCREEN HCG URINE1985-10-01
K841456 — VENTREXYME EIA CONTROLS IMMUNOASSAY1984-05-21
K833960 — VENTREX PREGNANCY TEST KIT ENZYME1984-02-03
K833989 — VENTREZYME THEOPHYLLINE IMMUNOASSAY1984-01-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.